Health industry year in review 2025: Norway makes global strides

Systematic activities on the part of the initiative, more strategic partnerships and international engagement have delivered measurable results, positioning Norwegian health and life science companies for sustainable growth.

Here is a selection of success stories from 2025:

Norway’s confidence was evident in radiopharma. On a trade mission to Japan in the spring, which included a high-profile day at Expo Osaka, Norwegian radiopharma and oncology companies were given strategic exposure to the Japanese market through a curated programme. Industry heavyweights like Bayer and GE HealthCare, together with clinicians from Oslo University Hospital, opened important doors for innovators such as Agilera and Norwegian Medical Cyclotron Centre as well as demonstrating that a unified effort benefits both large and small Norwegian companies alike.

Norwegian companies connected at some of the world’s most important health and life science events, such as the JP Morgan Healthcare Conference and BIO International Convention in the US, DMEA in Germany, NHS Confederation in the UK and Nordic Life Science Days in Sweden. There they built new relationships, opening up commercial opportunities and access to capital that would have been out of reach a few years ago.

In connection with the signing of a German-Norwegian health agreement, leading digital providers met with the renowned Charité university hospital in Berlin. In addition, Norwegian expertise in military medicine and use of AI in clinical settings was showcased at a US-Norway business summit in connection with an official visit of the HRH Crown Prince Haakon to the US.

Norway also deepened its global partnerships in 2025. Notably, Mayo Clinic signed an agreement with the company Dossier Solutions to strengthen its digital platform for competence management.

The Mayo Clinic Berg Innovation Exchange signed MoUs with the University Hospital of North Norway and UiT The Arctic University of Norway, and two companies, Nordic Brain Tech and SynPlan, that will join the network. Innovation Norway also signed an MoU with the Mayo Clinic Berg Innovation Exchange to establish a Nordic hub in Norway.

Meanwhile, the Health Innovation Accelerator continued, with fruitful partnerships between the Mayo Clinic Berg Innovation Exchange, Innovation Norway and DNB//Back Bay, among others.

Sensio was named Supplier of the Year 2025 at Care Home Professional Leaders in Care Awards in the UK. Also in the UK, DNV Imatis is participating in the Royal Cornwall Hospitals NHS Trust’s “Silent Hospital Pilot Project”. Initial results show that post-natal stays have been reduced by 0.5 days, saving GBP 75 000 annually.

Vitalthings has delivered its solutions to leading German clinics − Universitätsmedizin Frankfurt, Alb Fils Klinikum Göppingen, Bundeswehrkrankenhaus Krankenpflegeschule Ulm and Wahrendorff Klinikum − to analyse workflows and generate early evidence of cost-benefit.

Dossier Solutions successfully completed a pilot project on digital competence management at University Hospital Bonn and University Medical Centre Göttingen in Germany and signed a strategic partnership agreement with Laerdal Medical and SingHealth in Singapore.

A recent report from Menon Economics confirms that Norwegian exports are continuing to expand, with growth mainly driven by pharmaceutical companies. However, new strong players are emerging in digital health and medical technology, demonstrating that the Norwegian health and life science is an industry gaining global traction

When it comes to the export initiative itself, in 2026 there will be greater focus on targeted measures and industry-led activities, such as trade missions and strategic partnerships, as well as activities to attract foreign investment – in collaboration with Norwegian embassies/consulates general and industrial clusters.